UK markets closed

NantHealth, Inc. (NH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7852-0.0539 (-6.42%)
At close: 04:00PM EST
0.7852 0.00 (0.00%)
After hours: 04:00PM EST
Sign in to post a message.
  • D
    Don
    Nice to see a bit of volume today. Fingers crossed it becomes a trend.
  • J
    John
    whoever is running this company is smashing it to death. issuing another 30 mil shares when they border $1, they are going to get delisted and that will kill the companies stock. doesn't need more stock they need profits and growth...
  • H
    Hervelo
    terrible
  • Y
    Yahoo Finance Insights
    NantHealth is up 10.40% to 1.04
  • Y
    Yahoo Finance Insights
    NantHealth reached a 52 Week low at 1.35
  • D
    Don
    $GBIM conversation
    Some interesting things going on starting today. 50/50 joint venture with PSS on global vaccination strategy.

    copied from stocktwits

    "$AMRS

    $CYTR

    $IBRX

    $GBIM

    $NH
    NOTE: announced it has entered into a 50:50 joint venture arrangement with ImmunityBio, Inc.(IBRX) , a clinical-stage immunotherapy company, to accelerate the commercialization of a leading next-generation COVID-19 vaccine.

    The parties have signed a binding term sheet, and a definitive agreement is in process and is expected to be executed within the next month pending standard closing conditions."

    Fingers crossed I had a momentary panic when it dropped 99%
  • M
    Max
    I'm seldom a short-term buyer, but I did sell out yesterday. Seeing after the hours action, that's probably not a bad thing. That being stated, I may look to rejoin once she settles a bit.
    MAX
  • C
    Cheryl
    CEO P. Soon-Shiong bought 1.689MM shares for $5MM @ $2.96 Apr 14. Keep in mind it is down 20.3% YTD.
  • G
    Good Ole Truth
    There must be something circulating to provide this much upside volatility....Buyout ?
  • V
    VegasMD
    I have a lot of NH, and have been waiting... averaging down and waiting... and waiting—-since they were on 60 minutes years ago... but it has been here before and retreated... hopefully now will create larger base....
  • J
    Joseph
    If you look at NK that's where NH is going. It's like Walmart and Sam's Club. Same owner same principle driving the company.
  • R
    Ranjan
    Its not short squeeze. The stock is worth $10.
  • J
    Joe
    $GBIM conversation
    $GBIM DD report is here! https://docs.google.com/document/d/1WYQ8D2eHDjkSi09stonYDLODuoancbtL7IigWgUc8XU/

    Items covered include company background, active pipeline description and market opportunity, patents, recent agreements between GBIM and IB that detail financial milestone payments, and more. All source links are included to verify the information.

    Please make sure to read the disclosure and of course, post any positive feedback or constructive criticism.

    P.S. - If you don't want to click the links directly, you can always copy the URL first.

    $NK $NH $CYTR $SRNE
    GlobeImmune Inc. Due Diligence Report High Level Overview 2 Brief Company Background 3 NantCell (ImmunityBio) Purchase 3 January 2020 GBIM & IB Licensing Agreement 4 Current GBIM Pipeline 5 Intellectual Property 8 Open Job Positions 9 Key Personnel
    GlobeImmune Inc. Due Diligence Report High Level Overview 2 Brief Company Background 3 NantCell (ImmunityBio) Purchase 3 January 2020 GBIM & IB Licensing Agreement 4 Current GBIM Pipeline 5 Intellectual Property 8 Open Job Positions 9 Key Personnel
    docs.google.com
  • N
    Nicholas
    1.56 pre-market... I like the nice solid gains each day. I prefer slow and steady vs boom and bust.
  • S
    Scotty Scott
    It's amazing how quiet NH is compared to NK. I wonder if the general public doesn't know they're related.
  • J
    Joe
    $GBIM conversation
    Just want to remind everyone that nothing has fundamentally changed with this gem. People in $NK, $NH and of course $CYTR should read the DD report I wrote on $GBIM to see where the value lies. More will be revealed in the future. Not by me, but by the only one that really matters here, Dr. PSS.

    Items covered include company background, active pipeline description and market opportunity, patents, recent agreements between GBIM and IB that detail financial milestone payments, and more. All source links are included to verify the information.

    https://docs.google.com/document/d/1WYQ8D2eHDjkSi09stonYDLODuoancbtL7IigWgUc8XU/
  • J
    Joel
    NH great stock will be up very soon. Now is the time to buy. This company is solid and will go places
  • R
    Relog
    actually did my research on this company...
    the president/CEO is a genius & he is amazing.
    i also looked into their platforms, it's incredible..
    defintely deserves more credit than this.
  • J
    Josh
    check out RSI and Volume oscillator, last time the stock price was this low accumulation was lowering as well. but now accumulation is far higher at the same price. Lots of indicators show this stock climbing back up.
  • c
    charles
    Added shares.. RNA/DNA tumor normal profiling. GPS. I believe all patients with NK Cancer treatment goes through NH.. NH in the past trades 30-50% of Nk.